WILD-TYPE P53 SUPPRESSES THE MALIGNANT PHENOTYPE IN BREAST-CANCER CELLS CONTAINING MUTANT P53 ALLELES

被引:0
|
作者
RUNNEBAUM, IB
YEE, JK
KIEBACK, DG
SUKUMAR, S
FRIEDMANN, T
机构
[1] UNIV CALIF SAN DIEGO,CTR MOLEC GENET,LA JOLLA,CA 92093
[2] SALK INST BIOL STUDIES,LA JOLLA,CA 92037
关键词
P53; TUMOR SUPPRESSION; BREAST CANCER; RETROVIRUS; GENE TRANSFER;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We have examined the effect of expression of a retrovirally mediated wild-type (wt) p53 allele on the neoplastic properties of five human breast cancer cell lines expressing mutant p53. After infection with the retroviral vector Lhp53RNL expressing both the neomycin phosphotransferase gene and the wt p53 gene, the ability of infected cells to form colonies in G418 selective medium was markedly reduced and their morphology demonstrated changes toward a flattened and enlarged phenotype. Employing a high multiplicity of infection (MOI) with Lhp53RNL without neo(R) selection, the replication of wt p53-reconstituted cells was greatly reduced. The ability of the genetically modified cells to produce colonies in semi-solid medium and to form tumors in recipient nude mice was also markedly suppressed, Restoration of wt p53 expression in human breast cancer cells expressing endogenous mt (mutant) p53 can suppress some aspects of the malignant phenotype by a trans-dominant mechanism.
引用
收藏
页码:1137 / 1144
页数:8
相关论文
共 50 条
  • [21] Radiosensitivity of human breast cancer cells transduced with wild-type p53 gene is influenced by the p53 status of parental cells
    Maeda, T
    Matsubara, H
    Koide, Y
    Sugaya, M
    Miyazawa, Y
    Tasaki, K
    Isono, K
    Ochiai, T
    Sakiyama, S
    Tagawa, M
    ANTICANCER RESEARCH, 2000, 20 (2A) : 869 - 874
  • [22] Wild-Type p53 Regulates Apoptosis of Human Breast Cancer Cells
    Zhang, Xuliang
    Yu, Guozheng
    Cai, Lei
    Jian, Ming
    Cai, Lixia
    Xu, Dong
    DISCOVERY MEDICINE, 2024, 36 (191) : 2445 - 2453
  • [23] The interaction between p53 and DNA topoisomerase I is regulated differently in cells with wild-type and mutant p53
    Gobert, C
    Skladanowski, A
    Larsen, AK
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (18) : 10355 - 10360
  • [24] SENSITIVITY OF COMPETITIVE HYBRIDIZATION FOR THE DETECTION OF MUTANT P53 ALLELES IN A BACKGROUND OF WILD-TYPE
    CARPENTER, K
    MORGAN, K
    DURRANT, LG
    HARDCASTLE, JD
    KALSHEKER, N
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1995, 23 (01) : S129 - S129
  • [25] Role of p53 in the inhibition of proliferation of gastric cancer cells expressing wild-type or mutated p53
    Ji, Wansheng
    Ma, Jingrong
    Zhang, Hongmei
    Zhong, Hua
    Li, Lei
    Ding, Na
    Jiao, Jianxin
    Gao, Zhixing
    MOLECULAR MEDICINE REPORTS, 2015, 12 (01) : 691 - 695
  • [26] Contribution of the p53 pathway in cancers that carry wild-type p53
    Ohki, Rieko
    CANCER SCIENCE, 2022, 113 : 1232 - 1232
  • [27] Molecular basis for the accelerated senescence response to doxorubicin in p53 wild-type and p53 null/mutant breast tumor cells.
    Di, Xu
    Gewirtz, David
    CANCER RESEARCH, 2009, 69
  • [28] Cadmium induces conformational modifications of wild-type p53 and suppresses p53 response to DNA damage in cultured cells
    Meplan, Catherine
    Mann, Kris
    Hainautt, Pierre
    Journal of Biological Chemistry, 274 (44): : 31663 - 31670
  • [29] Cadmium induces conformational modifications of wild-type p53 and suppresses p53 response to DNA damage in cultured cells
    Méplan, C
    Mann, K
    Hainaut, P
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (44) : 31663 - 31670
  • [30] Modulation of MDR/MRP by wild-type and mutant p53
    Bähr, O
    Wick, W
    Weller, M
    JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (05): : 643 - 645